Colin Stott
Chief Operating Officer at ALTEROLA BIOTECH, INC.
Net worth: 713 184 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Elsley | M | - | 7 years | |
| Guillermo Torre-Amione | M | - | 6 years | |
| Michael Land | M | 40 | 3 years | |
| Christopher Waddick | M | - | 6 years | |
| David Hitchcock | M | 61 | 2 years | |
| Jennifer Chao | F | 54 | 2 years | |
| Ning Qu | M | 56 | - | |
| Dominic Schiller | M | 60 | 3 years | |
| Timothy Rogers | M | 60 | 3 years | |
| Peter Pekos | M | - | 7 years | |
| Daniel Reshef | M | 73 | - | |
| Teri Loxam | F | 52 | 2 years | |
| Nathan Thompson | M | - | 1 years | |
| Blagoja Ristevski | M | - | 9 years | |
| Bernard Lim | M | - | 4 years | |
| Thomas Moffatt | M | - | 5 years | |
| Trevor Burns | M | - | 7 years | |
| Kelly Narine | M | - | 4 years | |
| Anne Tomalin | F | - | 3 years | |
| Kiernan Lynch | M | 36 | - | |
| Andrew Hamer | M | 62 | 3 years | |
| Andrea B. Parker | M | - | 5 years | |
| Michael Willner | M | 57 | 3 years | |
| John Geddes | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam George | M | 54 | 13 years | |
| Larson Elmore | M | 75 | - | |
| Terrence Lynch | M | 65 | 2 years | |
| Seamus McAuley | M | 48 | - | |
| Jonathan Michael Laughton | M | - | 9 years | |
| Scott Giacobello | M | 54 | 4 years | |
| Eldon Smith | M | 84 | 4 years | |
| Thomas Gerard Lynch | M | 67 | 10 years | |
| Iain Chalmers | M | - | 4 years | |
| Terry Rafih | M | 67 | 1 years | |
| Alicia Secor | F | 62 | 4 years | |
| Deborah Brown | F | - | 3 years | |
| Julian Gangolli | M | 66 | 4 years | |
| Stephen Wright | M | 71 | 13 years | |
| Catherine Mackey | M | 68 | 4 years | |
| Richard D. Forrest | M | 75 | - | |
| Geoffrey Guy | M | 70 |
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 8 years |
| Cabot Brown | M | 63 | 8 years | |
| David Kirk | M | 70 | 11 years | |
| James Noble | M | 65 | 14 years | |
| William Arthur Waldegrave | M | 78 | 4 years | |
| Peter Mountford | M | 66 | - | |
| Lalit Kumar Verma | M | 45 | - | |
| Hans Schram | M | 70 | - | |
| Volker Knappertz | M | 59 | 5 years | |
| Ado Mohammed | M | - | 2 years | |
| Christopher Tovey | M | 59 | 9 years | |
| Douglas B. Snyder | M | 60 | 4 years | |
| Richard Potts | M | - | - | |
| Minesh Patel | M | - | - | |
| Paul Whitney | M | 76 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 11 years |
| Darren Cline | M | 59 | 2 years | |
| Stephen D. Schultz | M | - | 7 years | |
| Jill Broadfoot | F | 63 | 1 years | |
| David Morrison | M | 65 | - | |
| Josh Eizen | M | 46 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 39 | 65.00% |
| Canada | 21 | 35.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Colin Stott
- Personal Network
